​

Artivion (AORT) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChartTranscripts

AORT Stock Forecast

Artivion (AORT) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $31.50, with a high of $33.00 and a low of $30.00. This represents a 0.90% increase from the last price of $31.22.

$15 $19 $23 $27 $31 $35 High: $33 Avg: $31.5 Low: $30 Last Closed Price: $31.22

AORT Stock Rating

Artivion stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

AORT Forecast vs Benchmarks

TypeNameUpside
StockArtivion0.90%
SectorHealthcare Stocks 25.20%
IndustryMedical Device Stocks6.39%

Price Target Trends

1M3M12M
# Anlaysts--5
Avg Price Target--$30.60
Last Closing Price$31.22$31.22$31.22
Upside/Downside---1.99%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2524---6
Dec, 2424---6
Nov, 2434---7
Oct, 2434---7
Sep, 2434---7
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 23, 2024Daniel StauderJMP Securities$33.00$26.5324.39%5.70%
Aug 09, 2024Suraj KaliaOppenheimer$30.00$25.3318.44%-3.91%
Jul 10, 2024Frank TakkinenLake Street$30.00$25.9415.65%-3.91%
Jul 02, 2024Frank TakkinenLoop Capital Markets$30.00$26.0215.30%-3.91%
May 07, 2024Mike MatsonNeedham$30.00$21.0742.38%-3.91%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Oct 23, 2024Stifel NicolausMarket OutperformMarket Outperformhold
Oct 23, 2024JMP SecuritiesMarket OutperformOutperforminitialise
Oct 23, 2024JMP SecuritiesMarket Outperforminitialise
Sep 27, 2024NeedhamBuyBuyhold
Sep 13, 2024Stifel NicolausBuyBuyhold
Aug 09, 2024OppenheimerOutperformOutperformhold
Jul 02, 2024NeedhamBuyBuyhold
Jul 02, 2024Lake StreetBuyBuyhold
May 07, 2024NeedhamBuyBuyhold
Sep 26, 2022OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-0.44$-0.38$-0.48$-0.75---
Avg Forecast$-0.40$0.07$-0.66$-0.74$0.01$0.14$0.40
High Forecast$-0.40$0.07$-0.66$-0.75$0.01$0.14$0.27
Low Forecast$-0.39$0.07$-0.64$-0.73$0.01$0.14$0.49
Surprise %10.00%-642.86%-27.27%1.35%---

Revenue Forecast

$200M $260M $320M $380M $440M $500M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$253.23M$298.84M$313.79M$354.00M---
Avg Forecast$251.78M$297.24M$314.34M$349.64M$392.03M$430.23M$477.49M
High Forecast$249.08M$294.06M$310.06M$349.59M$391.93M$426.80M$477.48M
Low Forecast$253.95M$299.81M$317.05M$349.69M$392.13M$433.66M$477.50M
Surprise %0.58%0.54%-0.18%1.25%---

Net Income Forecast

$-35M $-24M $-13M $-2M $9M $20M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-16.68M$-14.83M$-19.19M$-30.69M---
Avg Forecast$-16.20M$2.72M$-26.73M$-30.57M$338.27K$5.62M$19.52M
High Forecast$-16.38M$2.68M$-27.03M$-30.65M$332.31K$5.52M$11.00M
Low Forecast$-15.97M$2.75M$-26.25M$-29.59M$344.23K$5.71M$19.96M
Surprise %3.00%-646.13%-28.19%0.40%---

AORT Forecast FAQ

Is Artivion stock a buy?

Artivion stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Artivion is a favorable investment for most analysts.

What is Artivion's price target?

Artivion's price target, set by 4 Wall Street analysts, averages $31.5 over the next 12 months. The price target range spans from $30 at the low end to $33 at the high end, suggesting a potential 0.90% change from the previous close price of $31.22.

How does Artivion stock forecast compare to the average forecast of its sector, industry, and investment themes?

Artivion stock forecast shows a 0.90% upside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the medical device stocks industry (6.39%).

What is the breakdown of analyst ratings for Artivion over the past three months?

  • January 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 42.86% Strong Buy, 57.14% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Artivion’s EPS forecast?

Artivion's average annual EPS forecast for its fiscal year ending in December is 0.01 for 2024, a -101.33% decrease from the reported $-0.75 in 2023. The prediction for 2025 is $0.14, and $0.4 for 2026.

What is Artivion’s revenue forecast?

Artivion's average annual revenue forecast for its fiscal year ending in December is $392.03M for 2024, a 10.74% increase from the reported $354M in 2023. The forecast for 2025 is $430.23M, and $477.49M for 2026.

What is Artivion’s net income forecast?

For its fiscal year ending in December, Artivion's average annual net income forecast is $338.27K for 2024, reflecting a -101.10% decrease from the reported $-30.69M in 2023. The projection for 2025 is $5.62M, and $19.52M for 2026.